SERA-SCANDIA A/S: Financial statements 2015
CVR: 14605185
Source: annual report 2015, Danish Business Authority
01/04/2014 – 31/03/2015
SERA-SCANDIA A/S (CVR 14605185) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 80,853 and a net result of DKK -3,721,848 compared with DKK -3,512,674 the year before. That is an increase of 11.4% compared with the year before. The profit margin was -4,603.2%. Equity in the 2015 report amounted to DKK 28,958,607. The solvency ratio was 41.4%.
- Revenue
- DKK 80,853
- Gross Profit
- DKK -17,553
- Profit/Loss
- DKK -3,721,848
- Equity
- DKK 28,958,607
- Total Assets
- DKK 69,977,067
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 81K | -18K | -3.7M | 29M | - |
| 2014 | 73K | 52K | -3.5M | 32.7M | - |
| 2013 | 0 | 0 | -8.8M | 36.2M | - |
Official annual report
How creditworthy is SERA-SCANDIA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout SERA-SCANDIA A/S
SERA-SCANDIA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1990. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SERA-SCANDIA ApS and VICH 2604 ApS. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Christian Lykkehus Sørensen and Nicolas Bødtker Nielsen. The company is owned by Danbiotech Inc.. The company has 16 employees (2026). In 2025, the company reported a gross profit of DKK 40,586,000 and a net result of DKK -7,801,000 compared with DKK 2,203,000 the year before. Equity in the 2025 report amounted to DKK 272,104,000.